Prospective observational study to evaluate clinical utility of FoundationObe CDx
Not Applicable
- Conditions
- gastrointestinal cancer, rare cancer and cancer of unknown primary
- Registration Number
- JPRN-UMIN000034830
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients without available tumor tissue 2. Patients judged to be inappropriate for the study by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection rate of actionable/druggable cancer genomic alterations using FoundationOne CDx
- Secondary Outcome Measures
Name Time Method